Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 33.96% Profit, Validating QuantWave's Analytics

May 19, 2023
ELI LILLY AND COMPANY has successfully reached the price target forecast set by QuantWave, delivering a profit of 33.96% for investors who followed the prediction. The forecast signal was initiated on March 21, 2023, when the stock was priced at 325.54 $. The direction predicted was long, and on May 19, 2023, the stock reached the target price of 436.12 $, confirming the accuracy of the forecast.

This achievement showcases the effectiveness of QuantWave's analytics in providing actionable insights for investors. The market analysis indicates that ELI LILLY AND COMPANY experienced positive momentum during the forecast period, potentially driven by strong financial performance, positive industry trends, or other market factors that supported the stock's movement towards the predicted target price.

The successful forecast for ELI LILLY AND COMPANY demonstrates the value of QuantWave's automated forecasting platform in helping users identify profitable trading opportunities. By leveraging advanced algorithms and data analysis, QuantWave offers accurate predictions for a wide range of stocks, empowering investors to make informed decisions and capitalize on market movements.

For investors interested in enhancing their understanding of QuantWave's investment strategy, exploring the educational resources provided by QuantSchool is recommended. QuantSchool offers a comprehensive professional framework for using the QuantWave forecasting system effectively, highlighting key principles for generating consistent income and maximizing investment returns.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

LLYFebruary 25, 2025Major Stock Movement: Lilly to participate in TD Cowens 45th Annual Health Care Conference  ~2 min.

Eli Lilly and Company (LLY) has recently caught the attention of investors as it prepares to participate in the TD Cowens 45th Annual Health Care Conference....

AXPJanuary 15, 2025American Express Company Hits QuantWave's Price Target Forecast with 14.92% Profit  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long signal for American Express Company on October 22, with a price of $270.86....

GOOGLMay 16, 2024ALPHABET INC. Hits Price Target Forecast on QuantWave with 23.08% Profit  ~1 min.

ALPHABET INC. has successfully reached the price target forecast set by QuantWave, resulting in a profitable outcome of 23.08%....

TTMIJune 24, 2025TTM Technologies, Inc. Hits Price Target Forecast with 57.07% Profit — A Triumph for QuantWave's Analytics  ~1 min.

TTM Technologies, Inc. has successfully reached the price target forecast set by QuantWave, achieving a significant profit of 57.07%....

EDSeptember 3, 2024CONSOLIDATED EDISON, INC. Hits Price Target Forecast with 13.36% Profit  ~1 min.

CONSOLIDATED EDISON, INC. has successfully achieved the price target forecast set by QuantWave on August 31, 2022. The forecast indicated a long position with a price of $88....

LYFTMarch 4, 2025LYFT, INC. Hits QuantWave's Forecast Price Target with 19.52% Profit  ~1 min.

LYFT, INC. has successfully achieved the price target forecasted by QuantWave, resulting in a profit of 19.52%. The forecast signal was issued on December 11, 2024, with the stock price at $15....